CRIS Current Research Information System

BAGNOLINI, GRETA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.853
EU - Europa 1.063
NA - Nord America 830
SA - Sud America 162
AF - Africa 69
OC - Oceania 31
Totale 4.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 798
IT - Italia 564
CN - Cina 542
SG - Singapore 424
VN - Vietnam 340
HK - Hong Kong 149
BR - Brasile 134
KR - Corea 113
DE - Germania 110
IN - India 96
GB - Regno Unito 64
FR - Francia 62
NL - Olanda 54
JP - Giappone 52
AU - Australia 31
CI - Costa d'Avorio 30
IE - Irlanda 30
FI - Finlandia 28
SE - Svezia 26
IR - Iran 19
PK - Pakistan 19
RU - Federazione Russa 18
CA - Canada 17
DK - Danimarca 17
TW - Taiwan 16
CH - Svizzera 15
ES - Italia 15
PH - Filippine 14
AT - Austria 13
MX - Messico 13
AR - Argentina 12
BD - Bangladesh 12
PL - Polonia 11
TG - Togo 10
TH - Thailandia 9
TR - Turchia 9
ZA - Sudafrica 8
HR - Croazia 7
ID - Indonesia 7
JO - Giordania 6
MA - Marocco 6
BG - Bulgaria 5
BY - Bielorussia 5
IQ - Iraq 5
PY - Paraguay 5
CZ - Repubblica Ceca 4
EG - Egitto 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
GR - Grecia 3
IL - Israele 3
MY - Malesia 3
NG - Nigeria 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
BE - Belgio 2
CO - Colombia 2
DZ - Algeria 2
HU - Ungheria 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
SM - San Marino 2
AM - Armenia 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
LT - Lituania 1
MM - Myanmar 1
MU - Mauritius 1
MW - Malawi 1
NP - Nepal 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 4.008
Salva come PNG Salva come JPEG
Città #
Singapore 309
Hefei 199
Bologna 151
Ashburn 150
Hong Kong 128
Hanoi 99
Ho Chi Minh City 93
Seoul 86
San Jose 69
Milan 59
Beijing 43
Tokyo 43
Fairfield 36
Florence 32
Santa Clara 31
Abidjan 30
Dublin 30
Chandler 29
Los Angeles 29
Seattle 27
Lauterbourg 26
Sydney 26
Frankfurt am Main 25
Houston 24
Rome 23
Dallas 22
Falkenstein 22
Helsinki 21
Bengaluru 20
Council Bluffs 19
Southend 16
Cambridge 15
Da Nang 15
New York 15
São Paulo 15
Genoa 14
Jalandhar 14
Redmond 14
Woodbridge 14
Munich 13
Haiphong 12
Jhelum 12
Modena 12
Nanjing 12
Verona 12
Amsterdam 11
Boardman 11
Copenhagen 11
Forlì 11
Vienna 11
Lomé 10
Shanghai 10
Stockholm 10
Turin 10
Boston 9
Brooklyn 9
Buffalo 9
Calcinelli 9
Claymont 9
Porto Alegre 9
Redondo Beach 9
Tianjin 8
Toronto 8
Wilmington 8
Biên Hòa 7
Chicago 7
Guangzhou 7
Hyderabad 7
London 7
Minneapolis 7
Naples 7
Zurich 7
Athens 6
Atlanta 6
Berlin 6
Düsseldorf 6
Mexico City 6
Montreal 6
Nijmegen 6
Nuremberg 6
Philadelphia 6
Piacenza 6
Princeton 6
Tehran 6
Wuhan 6
Zagreb 6
Amman 5
Barcelona 5
Chennai 5
Denver 5
Jakarta 5
Johannesburg 5
Lucca 5
Lucknow 5
Madrid 5
Minsk 5
Paris 5
Perugia 5
Poplar 5
Reggio Emilia 5
Totale 2.498
Salva come PNG Salva come JPEG
Nome #
Design and synthesis of small molecules targeting pre-miRNA21 toward the development of ribonuclease targeting chimeras (RIBOTACs) to regulate the oncogenic miRNA21 317
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 275
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 270
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 259
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer 250
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives 224
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity 224
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 199
Inhibition of Urease, a Ni-Enzyme: The Reactivity of a Key Thiol With Mono- and Di-Substituted Catechols Elucidated by Kinetic, Structural, and Theoretical Studies 199
Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer 187
Targeting RNA degradation with small molecules: design and synthesis of selective RNA binders and development of ribonuclease targeting chimeras (RIBOTACs) 183
Design and synthesis of RAD51-BRCA2 protein-protein interaction disruptors to trigger synthetic lethality with Olaparib in pancreatic cancer cells 178
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and achieve synthetic lethality in pancreatic cancer cells 158
Identification of RAD51-BRCA2 Inhibitors Using N-Acylhydrazone-Based Dynamic Combinatorial Chemistry 154
Dihydroquinoline pyrazoline-based compound as a new RAD51-BRCA2 protein-protein disruptor to trigger synthetic lethality in pancreatic cancer 152
Design and synthesis of RAD51-BRCA disruptors to inhibit homologous recombination and achieve synthetic lethality in cancer cells 118
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 111
Triggering RNA degradation with small molecules: development of RIBOnuclease TArgeting Chimeras (RIBOTACs) 103
Design and synthesis of small molecules binders of pre-miRNA21 toward the regulation of oncogenic miRNA21 98
DESIGN AND SYNTHESIS OF SMALL MOLECULES TARGETING PRE-MIRNA21 TOWARD THE DEVELOPMENT OF RIBONUCLEASE TARGETING CHIMERAS (RIBOTACS) TO REGULATE THE ONCOGENIC MIRNA21 73
Identification of RAD51-BRCA2 inhibitors using N-acylhydrazone-based dynamic combinatorial chemistry 64
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in cancer treatment 61
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid Series 60
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and synergize with Olaparib as new anticancer drug discovery concept 55
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 54
Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA 44
Totale 4.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 4 5 5
2021/202291 10 4 4 3 5 5 7 14 8 5 12 14
2022/2023142 8 19 7 17 10 9 7 10 21 10 8 16
2023/2024236 11 9 4 7 18 19 21 7 10 18 70 42
2024/2025939 47 33 35 22 85 71 57 21 61 126 132 249
2025/20262.492 301 328 251 332 240 122 248 144 424 102 0 0
Totale 4.070